Table 4.
Circulating microRNAs in hepatitis B virus infection and their role in necroinflammation vs fibrosis
| Circulating microRNA | microRNA regulation | Clinical significance in HBV infection | Ref. |
| miR-122 | ↑ | Correlates with the necroinflammatory activity, HBsAg and HBV DNA; Also correlated with ≥ F2 stage of liver fibrosis | Waidmann et al[103], Ji et al[109], Wang et al[106] |
| miR-210 | ↑ | Marker of necroinflammation; Varies with the severity of HBV hepatitis | Song et al[140] |
| miR-125 (-125a-5p/ -125b) | ↑ | Correlates with HBV intrahepatic replication and necroinflammatory activity | Li et al[141], Zheng et al[134] |
| miR-124 | ↑ | Marker of HBV-associated necroinflammation | Wang et al[142] |
| miR-29 | ↓ | Marker of liver fibrosis irrespective of aetiology | Xing et al[139] |
| miR-223 | ↓ | Marker of liver fibrosis, decreases with the progression to cirrhosis | Bao et al[43] |
| miR-185 | ↑ | Increases in advanced HBV fibrosis; Could play a therapeutic role in HBV gene suppression in tumoral cells | Li et al[136], Fan et al[143] |
↑ means upregulation. ↓ means downregulation. HBsAg: Hepatitis B surface antigen; HBV: Hepatitis B virus; miR: MicroRNA.